Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biostage Inc (OTCQB:BSTG)

0.0558
Delayed Data
As of Dec 14
 0.00 / 0.00%
Today’s Change
0.05
Today|||52-Week Range
1.00
-93.73%
Year-to-Date
No recent news for Biostage Inc.

Today’s Trading

Previous close0.06
Today’s open0.05
Day’s range0.05 - 0.06
Volume192,922
Average volume (3 months)1,106,668
Market cap$2.2M
Data as of 3:43pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+30.48%
Earnings growth (this year)+42.47%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.51%
P/E ratio--
Price/Sales173.34
Price/Book0.54

Competitors

 Today’s
change
Today’s
% change
AMDAAmedica Corp0.000.00%
--Suda Pharmaceuticals...0.000.00%
CYTXCytori Therapeutics ...0.000.00%
AEMDAethlon Medical Inc0.000.00%
Data as of 4:00pm ET, 12/14/2017

Financials

Last reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$82.0K
Annual profit (last year)-$11.6M
Net profit margin-14,120.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Independent Director
James J. McGorry
Director-Quality &
Operations
Ginger A. Abraham-Freel
Corporate headquarters
Holliston, Massachusetts

Forecasts